Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Younus

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Current Oncology (Toronto, Ont.)|August 11, 2010
Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidenceJ Younus, S Verma, J Franek, et al.
Biochimica Et Biophysica Acta|March 23, 1994
Inhibition by cyclic AMP and phorbol esters of sodium-dependent uptake of phosphate by rat hepatocytesM J Younus, K Jouhal, P J Butterworth
Current Oncology (Toronto, Ont.)|January 10, 2013
Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysisJ Younus, T Vandenberg, M Jawaid, et al.
Current Oncology (Toronto, Ont.)|August 22, 2007
Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guidelineS Verma, J Younus, D Stys-Norman, et al.
Current Oncology (Toronto, Ont.)|May 6, 2008
Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guidelineS Verma, J Younus, A E Haynes, et al.
Current Oncology (Toronto, Ont.)|August 13, 2009
An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancerS Verma, S Sehdev, A Joy, et al.
The Annals of Thoracic Surgery|July 3, 2013
An effective modification to simplify the right atrial lesion set of the Cox-cryomazeFaisal H Cheema, Muhammad J Younus, Arham Pasha, et al.
Current Oncology (Toronto, Ont.)|December 15, 2010
What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer?E Yu, P Tai, R Malthaner, et al.
Innovations (Philadelphia, Pa.)|April 11, 2013
Does cryomaze injure the circumflex artery?: a preliminary search for occult postprocedure stenosesFaisal H Cheema, Mohammad B Pervez, Mansoor Mehmood, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancerT W Zhang, G B Rodrigues, A V Louie, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Current Oncology (Toronto, Ont.)|August 11, 2010
Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidenceJ Younus, S Verma, J Franek, et al.
Biochimica Et Biophysica Acta|March 23, 1994
Inhibition by cyclic AMP and phorbol esters of sodium-dependent uptake of phosphate by rat hepatocytesM J Younus, K Jouhal, P J Butterworth
Current Oncology (Toronto, Ont.)|January 10, 2013
Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysisJ Younus, T Vandenberg, M Jawaid, et al.
Current Oncology (Toronto, Ont.)|August 22, 2007
Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guidelineS Verma, J Younus, D Stys-Norman, et al.
Current Oncology (Toronto, Ont.)|May 6, 2008
Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guidelineS Verma, J Younus, A E Haynes, et al.
Current Oncology (Toronto, Ont.)|August 13, 2009
An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancerS Verma, S Sehdev, A Joy, et al.
The Annals of Thoracic Surgery|July 3, 2013
An effective modification to simplify the right atrial lesion set of the Cox-cryomazeFaisal H Cheema, Muhammad J Younus, Arham Pasha, et al.
Current Oncology (Toronto, Ont.)|December 15, 2010
What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer?E Yu, P Tai, R Malthaner, et al.
Innovations (Philadelphia, Pa.)|April 11, 2013
Does cryomaze injure the circumflex artery?: a preliminary search for occult postprocedure stenosesFaisal H Cheema, Mohammad B Pervez, Mansoor Mehmood, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancerT W Zhang, G B Rodrigues, A V Louie, et al.
Pageof 3